Caas Capital Management LP Avidity Biosciences, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$10.06 - $22.66 $251,500 - $566,500
25,000 New
25,000 $554,000
Q4 2021

Feb 14, 2022
SELL
$20.4 - $28.66 $2.86 Million - $4.02 Million
-140,354 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$18.16 - $25.21 $2.55 Million - $3.54 Million
140,354 New
140,354 $3.46 Million
Q4 2020

Feb 12, 2021
SELL
$24.73 - $35.12 $370,950 - $526,800
-15,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$26.62 - $31.5 $399,300 - $472,500
15,000 New
15,000 $424,000

Others Institutions Holding RNA

# of Institutions
253
Shares Held
107M
Call Options Held
224K
Put Options Held
161K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.51B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email